APRE earnings date and last-quarter result: last quarter beat, P/E -0.38. Updated 2026-07-23.
Aprea Therapeutics (APRE) Research Hub
Aprea Therapeutics (APRE) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.449 USD (-13.27%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.38, market cap 0.00B. This hub links to the full technical, earnings and options research available for APRE.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.449 USD (-13.27%) |
| 52-week range | 0.41 USD – 1.16 USD |
| Trend regime | Range |
| 14-day RSI | 27.8 (Oversold) |
| Trailing P/E | -0.38 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
Available research for APRE
Covered Call on APRE: how it works, illustrative setup around the real 0.449 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on APRE: how it works, illustrative setup around the real 0.449 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on APRE: how it works, illustrative setup around the real 0.449 USD price, max profit/loss, breakeven and when to use it. Educational.
APRE technical analysis: range, last 0.449 USD, RSI 27.8, 52w range 0.41 USD–1.16 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is APRE in?
Aprea Therapeutics (APRE) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is APRE in an uptrend or downtrend?
As of 2026-10-26, APRE is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is APRE's trailing P/E ratio?
APRE's trailing P/E is -0.38, with a market cap of 0.00B. See the earnings research page for full valuation detail.